Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Pyykkö, Okko T ^a   Lumela, Miikka ^a   Rummukainen, Jaana ^a   Nerg, Ossi ^a   Seppälä, Toni T ^b   Herukka, Sanna Kaisa ^a,b   Koivisto, Anne M ^a,b   Alafuzoff, Irina ^c   Puli, Lakshman ^b   Savolainen, Sakari ^a   Soininen, Hilkka ^a,b   Jääskeläinen, Juha E ^a   Hiltunen, Mikko ^b   Zetterberg, Henrik ^d   Leinonen, Ville ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CYTOKINE; DNA; GAMMA INTERFERON; ISOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; APOLIPOPROTEIN E4; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ANASTOMOSIS; ARTICLE; BRAIN BIOPSY; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROSURGERY; NORMOTENSIVE HYDROCEPHALUS; PROGNOSIS; PROTEIN PHOSPHORYLATION; VERY ELDERLY; BIOPSY; BRAIN; FINLAND; GENETICS; HYDROCEPHALUS, NORMAL PRESSURE; METABOLISM; MIDDLE AGED; PATHOLOGY; REGISTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; BIOPSY; BRAIN; CYTOKINES; FEMALE; FINLAND; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; REGISTRIES;

EID: 84898657736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091974     Document Type: Article

References (44)

1. Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2:307-327.
2. Adams RD, Fischer CM, Hakim S, Ojemann RG, Sweet WH (1965) Symptomatic occult hydrocephalus with "normal" cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 273:117-126.
3. Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Sutela A, et al. (2012) Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 38:72-86.
4. Cusimano MD, Rewilak D, Stuss DT, Barrera-Martinez JC, Salehi F, et al. (2011) Normal-pressure hydrocephalus: Is there a genetic predisposition? Can J Neurol Sci 38:274-281.
5. McGirr A, Cusimano MD (2012) Familial aggregation of idiopathic normal pressure hydrocephalus: Novel familial case and a family study of the NPH triad in an iNPH patient cohort. J Neurol Sci 321:82-88.
6. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57:S4-16; discussion ii-v.
7. Sundström N, Andersson K, Marmarou A, Malm J, Eklund A (2010) Comparison between 3 infusion methods to measure cerebrospinal fluid outflow conductance. J Neurosurg 113:1294-1303.
8. Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Tamminen JN, et al. (2010) Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease. Ann Neurol 68:446-453.
9. Eide PK, Sorteberg W (2010) Diagnostic intracranial pressure monitoring and surgical management in idiopathic normal pressure hydrocephalus: A 6-year review of 214 patients. Neurosurgery 66:80-91.
10. Koivisto AM, Alafuzoff I, Savolainen S, Sutela A, Rummukainen J, et al. (2013) Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 72:1-8.
11. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
12. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259. (Pubitemid 27435070)
13. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800. (Pubitemid 34663580)
14. Querfurth HW, La Ferla FM (2010) Alzheimer's disease. N Engl J Med 362:329-344.
15. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356. (Pubitemid 34790756)
16. Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, et al. (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535-540.
17. Seppälä TT, Nerg O, Koivisto AM, Rummukainen J, Puli L, et al. (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78:1568-1575.
18. Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, et al. (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh compound B. Arch Neurol 65:1304-1309.
19. Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, et al. (2012) [(18) F]flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid b detection in living subjects with normal pressure hydrocephalus: Pooled analysis of four studies. Acta Neuropathol 124:833-845.
20. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol 2:506-511. (Pubitemid 36876108)
21. Pyykkö OT, Helisalmi S, Koivisto AM, Mölsä JA, Rummukainen J, et al. (2012) APOE4 predicts amyloid-b in cortical brain biopsy but not idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 83:1119-1124.
22. Tarnaris A, Toma AK, Chapman MD, Keir G, Kitchen ND, et al. (2011) Use of cerebrospinal fluid amyloid-beta and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 115:145-150.
23. Patel S, Lee EB, Xie SX, Law A, Jackson EM, et al. (2012) Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 9:7-8118-9-7.
24. Turner PR, O'Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1-32. (Pubitemid 36966639)
25. Selnes P, Blennow K, Zetterberg H, Grambaite R, Rosengren L, et al. (2010) Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid. Cerebrospinal Fluid Res 7:10-8454-7-10.
26. Ray B, Reyes PF, Lahiri DK (2011) Biochemical studies in normal pressure hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (abeta) peptide and phospho-tau. J Psychiatr Res 45:539-547.
27. Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, et al. (2012) Soluble amyloid precursor protein a in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol 20:236-242.
28. Jeppsson A, Zetterberg H, Blennow K, Wikkelsö C (2013) Idiopathic normalpressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers. Neurology 80:1385-1392.
29. Chakraborty S, Kaushik DK, Gupta M, Basu A (2010) Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 88:1615-1631.
30. Tarnaris A, Toma AK, Kitchen ND, Watkins LD (2009) Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus. Biomark Med 3:787-805.
31. Cacabelos R, Barquero M, García P, Alvarez XA, Varela De Seijas E (1991) Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol 13:455-458.
32. Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, et al. (2005) Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 62:1591-1594. (Pubitemid 41434566)
33. Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, et al. (2006) Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol Sci 27:33-39. (Pubitemid 44026855)
34. Tarkowski E, Tullberg M, Fredman P, Wikkelsö C (2003) Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging 24:707-714. (Pubitemid 37288869)
35. Leinonen V, Menon LG, Carroll RS, Dello Iacono D, Grevet J, et al. (2011) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimers Dis 2011:312526.
36. Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C (1998) CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 50:1122-1127. (Pubitemid 28212848)
37. Tullberg M, Blennow K, Månsson JE, Fredman P, Tisell M, et al. (2007) Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur J Neurol 14:248-254. (Pubitemid 46384850)
38. Agren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, et al. (2007) CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 116:333-339. (Pubitemid 47537413)
39. Tullberg M, Blennow K, Månsson JE, Fredman P, Tisell M, et al. (2008) Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res 5:9-8454-5-9.
40. Whitaker JN (1998) Myelin basic protein in cerebrospinal fluid and other body fluids. Mult Scler 4:16-21. (Pubitemid 28077431)
41. Sutton LN, Wood JH, Brooks BR, Barrer SJ, Kline M, et al. (1983) Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg 59:467-470. (Pubitemid 13048142)
42. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, et al. (1993) Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 121:598-602. (Pubitemid 23112654)
43. Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, et al. (2008) Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 65:1102-1107.
44. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, et al. (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512-519. (Pubitemid 43358072)